Status: Recruiting
Exclusive Human-milk in Preterm NEOnates and Early VASCular Aging Risk Factors (NEOVASC)
Early vascular aging has its origins in fetal and neonatal life. The NEOVASC clinical trial aims to determine the effects of an exclusive human milk diet in extremely preterm infants on long-term cardiovascular health.
Participants needed: 200
Trial details
Age: 1-5Biological sex: AllType: InterventionalSponsor: Prolacta BioscienceUpdated: Aug 29, 2025Locations: 1
Eligibility criteria
Extremely preterm infants with a birth weight of 500-1250g. [+2]
Infants with a birth weight <500g or >1250g [+10]